CIPLA Fact Sheet, CIPLA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA Fact Sheet    (CIPL)


Going LIVE Today at 5pm: The EV Gold Rush Special Event


Here is the latest financial fact sheet of CIPLA. For more details, see the CIPLA quarterly results and CIPLA share price and chart. For a sector overview, read our pharmaceuticals sector report.

CIPLA Price History

Price Rs 975.4
Mkt Cap Rs m 786,966
Vol '000 34.5
P/E X 30.7
P/CF X 22.7
EPS (TTM) Rs 31.7
1 Day % -0.3
No. of shares m 806.81
1 Week % 5.9
1 Month % -2.4
1 Year % 7.9
52 week H/L Rs 1,083.2/850.0
As on May 23, 2022 02:48:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

CIPLA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
CIPLA EQUITY SHARE DATA
High Rs622663678586879 
Low Rs458479484357411 
Sales per share (Unadj.) Rs176.0187.5203.1212.5237.6 
Earnings per share (Unadj.) Rs13.017.618.719.229.8 
Diluted earnings per shareRs12.917.618.719.229.8 
Cash flow per share (Unadj.) Rs29.434.135.233.843.0 
Dividends per share (Unadj.) Rs2.003.003.004.005.00 
Adj. dividends per shareRs1.992.993.004.005.00 
Avg Dividend yield %0.40.50.50.80.8 
Book value per share (Unadj.) Rs155.1175.9185.6194.9226.7 
Adj. book value per shareRs154.7175.5185.4194.7226.6 
Shares outstanding (eoy) m804.51805.12805.70806.24806.46 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x3.13.02.92.22.7 
Avg P/E ratio x41.732.431.024.621.6 
P/CF ratio (eoy) x18.416.816.514.015.0 
Price / Book Value ratio x3.53.23.12.42.8 
Dividend payout %15.417.016.020.816.8 
Avg Mkt Cap Rs m434,516459,723468,032379,858519,826 
No. of employees `000NANANANANA 
Total wages/salary Rs m26,33826,90128,56530,27032,518 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
CIPLA INCOME DATA
Net Sales Rs m141,583150,922163,624171,320191,596 
Other income Rs m2,2873,5774,7663,6942,698 
Total revenues Rs m143,870154,498168,390175,014194,294 
Gross profit Rs m24,75827,48930,97331,80842,487 
Depreciation Rs m13,22913,22813,26311,74710,677 
Interest Rs m1,5941,1421,6841,9741,607 
Profit before tax Rs m12,22216,69520,79121,78232,901 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,7982,5015,6956,3128,888 
Profit after tax Rs m10,42414,19415,09615,47024,013 
Gross profit margin %17.518.218.918.622.2 
Effective tax rate %14.715.027.429.027.0 
Net profit margin %7.49.49.29.012.5 
CIPLA BALANCE SHEET DATA
Current assets Rs m88,036108,141124,266117,062132,095 
Current liabilities Rs m33,88938,32237,71543,93145,916 
Net working cap to sales %38.246.352.942.745.0 
Current ratio x2.62.83.32.72.9 
Inventory Days Days4549725068 
Debtors Days Days78987 
Net fixed assets Rs m120,822118,588113,353117,166116,277 
Share capital Rs m1,6091,6101,6111,6131,613 
"Free" reserves Rs m123,207140,019147,941155,487181,232 
Net worth Rs m124,816141,629149,552157,100182,844 
Long term debt Rs m36,45436,62138,30123,69312,028 
Total assets Rs m208,858226,729237,619234,228248,372 
Interest coverage x8.715.613.312.021.5 
Debt to equity ratio x0.30.30.30.20.1 
Sales to assets ratio x0.70.70.70.70.8 
Return on assets %5.86.87.17.410.3 
Return on equity %8.410.010.19.813.1 
Return on capital %8.610.012.013.117.7 
Exports to sales %35.333.133.932.231.3 
Imports to sales %6.813.911.63.410.9 
Exports (fob) Rs m50,05049,88355,41955,17559,951 
Imports (cif) Rs m9,61621,03319,0415,90320,911 
Fx inflow Rs m51,06651,69157,41056,03668,051 
Fx outflow Rs m17,67821,03319,0415,90320,911 
Net fx Rs m33,38830,65838,36850,13347,140 
CIPLA CASH FLOW
From Operations Rs m 23,818 14,628 16,911 30,685 37,552 
From Investments Rs m -13,102 -8,540 -16,687 1,040 -23,872 
From Financial Activity Rs m -13,257 -3,855 -3,487 -29,488 -13,299 
Net Cashflow Rs m -2,478 2,431 -3,451 2,340 509 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 33.6%
Institution 48.6%
Non-Institution 17.7%
Total 100.0%
Free Float 66.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg Lower Parel, Mumbai - 400013
E-mail cosecretary@cipla.com Web www.cipla.com
Tel 022-24826000 Fax 022-224826120
Sector PHARMACEUTICALS Group CIPLA Group
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor V. Sankar Aiyar & Co.
CHM: Y K Hamied COMP SEC: Rajendra Chopra YEAR OF INC: 1935 BSE CODE: 500087 FV (Rs): 2 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    AUROBINDO PHARMA    

Compare CIPLA With:   SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    AUROBINDO PHARMA    




Today's Market

Sensex Trades Higher Even as Metal Stocks Bleed; Tata Steel & JSW Steel Fall 12%(10:30 am)

Asian share markets are lower today as persistent worries about inflation and rising interest rates dogged the global economic outlook and fresh selling in technology stocks weighed on Chinese markets.

Views on news

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK CIPLA

MORE ON CIPLA

CIPLA - TEVA PHARMA COMPARISON

COMPARE CIPLA WITH

MARKET STATS